Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion
Abbreviated Journal Title
apoptosis; myocardial infarction; reperfusion; SERINE-PROTEASE OMI/HTRA2; CASPASE ACTIVITY; INHIBITOR; PROTEINS; MITOCHONDRIA; XIAP; SMAC/DIABLO; INTERACTS; HTRA2; MICE; Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
Background - Omi/HtrA2 is a proapoptotic mitochondrial serine protease involved in caspase-dependent as well as caspase-independent cell death. However, the role of Omi/HtrA2 in the apoptotic cell death that occurs in vivo under pathological conditions remains unknown. The present study was designed to investigate whether Omi/HtrA2 plays an important role in postischemic myocardial apoptosis. Methods and Results - Male adult mice were subjected to 30 minutes of myocardial ischemia followed by reperfusion and treated with vehicle or ucf-101, a novel and specific Omi/HtrA2 inhibitor, 10 minutes before reperfusion. Myocardial ischemia/reperfusion significantly increased cytosolic Omi/HtrA2 content and markedly increased apoptosis. Treatment with ucf-101 exerted significant cardioprotective effects, as evidenced by less terminal dUTP nick end-labeling staining, a lower incidence of DNA ladder fragmentation, and smaller infarct size. Furthermore, treatment with ucf- 101 before reperfusion attenuated X-linked inhibitor of apoptosis protein degradation and inhibited caspase-9 and caspase-3 activities. Conclusion - Taken together, these results demonstrate for the first time that ischemia/reperfusion results in Omi/HtrA2 translocation from the mitochondria to the cytosol, where it promotes cardiomyocyte apoptosis via a protease activity - dependent, caspase-mediated pathway.
"Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion" (2005). Faculty Bibliography 2000s. 5420.